MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin

miR-1244/Myocyte Enhancer Factor 2D Regulatory Loop Contributes to the Growth of Lung Carcinoma

(2015) Rui Zhang et al.   DNA AND CELL BIOLOGY

Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase

(2014) C Xu et al.   ONCOGENE

miR-495 Enhances the Sensitivity of Non-Small Cell Lung Cancer Cells to Platinum by Modulation of Copper-Transporting P-type Adenosine Triphosphatase A (ATP7A)

(2013) Liqiang Song et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

(2012) Julian R. Molina et al.   MAYO CLINIC PROCEEDINGS

miRNAs as mediators of drug resistance

(2012) Sierk Haenisch et al.   Epigenomics

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)

(2011) Hai-Bo Bian et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

MicroRNA: Biogenesis, Function and Role in Cancer

(2010) Leigh-Ann MacFarlane et al.   CURRENT GENOMICS

Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells

(2010) Bo Song et al.   Molecular Cancer

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Origins and Mechanisms of miRNAs and siRNAs

(2009) Richard W. Carthew et al.   CELL

miRNAs modulate the drug response of tumor cells

(2009) XueMei Wu et al.   Science in China. Series C, Life sciences / Chinese Academy of Sciences